Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov 9:6:321.
doi: 10.3389/fped.2018.00321. eCollection 2018.

Invasive Meningococcal Disease in the Vaccine Era

Affiliations
Review

Invasive Meningococcal Disease in the Vaccine Era

Simon Nadel et al. Front Pediatr. .

Abstract

Infection with the meningococcus is one of the main causes of meningitis and septicaemia worldwide. Humans are the only natural reservoir for the meningococcus which is found primarily as a commensal inhabitant in the nasopharynx in ~10% of adults, and may be found in over 25% of individuals during adolescence. Prompt recognition of meningococcal infection and early aggressive treatment are essential in order to reduce mortality, which occurs in up to 10% of those with invasive meningococcal disease (IMD). This figure may be significantly higher in those with inadequate or delayed treatment. Early administration of effective parenteral antimicrobial therapy and prompt recognition and appropriate management of the complications of IMD, including circulatory shock and raised intracranial pressure (ICP), are critical to help improve patient outcome. This review summarizes clinical features of IMD and current treatment recommendations. We will discuss the evidence for immunization and effects of vaccine strategies, particularly following implementation of effective vaccines against Group B meningococcus.

Keywords: epidemiology; meningitis; meningococcal; sepsis; treatment; vaccine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pathophysiology of septic shock. Filled boxes are the treatment options. Taken from Welch and Nadel (15).

References

    1. Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet (2007) 369:2196–210. 10.1016/S0140-6736(07)61016-2 - DOI - PubMed
    1. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med. (2001) 344:1378–88. 10.1056/NEJM200105033441807 - DOI - PubMed
    1. Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine (2009) 27:B51–63. 10.1016/j.vaccine.2009.04.063 - DOI - PubMed
    1. World Health Organisation Meningitis A Nearly Eliminated in Africa Through Vaccination, Reaching More Than 235 Million People. Available online at: http://www.afro.who.int/search/node?keys=meningitis (Accessed June 1, 2018).
    1. European Centre for Disease Prevention and Control. Invasive Meningococcal Disease. Annual Epidemiological Report for 2015. Stockholm: ECDC; (2017).